Evidence map›Paper›PMID 40841711›Full record

ArticleThe EMBO journal2025

Soma-localized Rab39 inhibits synaptic autophagy by controlling trafficking of Atg9 vesicles.

Ayse Kilic, Gokhan Ozturan, Dirk Vandekerkhove, Sabine Kuenen, Jef Swerts, Esther Muñoz Pedrazo, Carles Calatayud Aristoy, Abril Escamilla Ayala, Nikky Corthout, Pablo Hernández Varas and 4 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ayse KilicVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0002-9369-8377
Gokhan OzturanVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0002-7874-3512
Dirk VandekerkhoveVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.
Sabine KuenenVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0001-9135-5293
Jef SwertsVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0002-3380-6030
Esther Muñoz PedrazoVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0002-7095-1851
Carles Calatayud AristoyVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium.
Abril Escamilla AyalaVIB BioImaging Core, VIB-Center for Brain and Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0002-5761-0999
Nikky CorthoutVIB BioImaging Core, VIB-Center for Brain and Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0003-1176-7277
Pablo Hernández VarasVIB BioImaging Core, VIB-Center for Brain and Disease Research, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0001-8664-9203
Stéphane PlaisanceVIB Nucleomics Core, Leuven, 3000, Belgium.ORCID http://orcid.org/0000-0002-1651-241X
Valerie UytterhoevenVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium. valerie.uytterhoeven@kuleuven.be.ORCID http://orcid.org/0000-0003-3100-2079
Eliana NachmanVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium. eliana.nachman@kuleuven.be.ORCID http://orcid.org/0000-0002-2069-6469
Patrik VerstrekenVIB-KU Leuven Center for Brain & Disease Research, Leuven, 3000, Belgium. patrik.verstreken@kuleuven.be.ORCID http://orcid.org/0000-0002-5073-5393

Funding

EC | European Research Council (ERC) AdG 101054310Fonds Wetenschappelijk Onderzoek (FWO) 1165925NFonds Wetenschappelijk Onderzoek (FWO) 11E2223NFonds Wetenschappelijk Onderzoek (FWO) 11O3225NFonds Wetenschappelijk Onderzoek (FWO) 1282123NFonds Wetenschappelijk Onderzoek (FWO) 151095Fonds Wetenschappelijk Onderzoek (FWO) G031324NFonds Wetenschappelijk Onderzoek (FWO) G0B8119N
6 · The paper itself

Abstract

Presynaptic terminals can be located far from the neuronal cell body and are thought to independently regulate protein and organelle turnover. Autophagy is a critical process for maintaining proteostasis, and its synaptic dysregulation is associated with neurodegenerative diseases. In this work, we report a soma-centered mechanism that regulates autophagy-controlled protein turnover at distant presynaptic terminals in Drosophila. We show that a central component of this system is Rab39, whose human homolog RAB39B is mutated in Parkinson's disease. Although Rab39 is localized in the soma, its loss of function or a human pathogenic mutation causes increased autophagy at presynaptic terminals, resulting in faster synaptic protein turnover and dopaminergic synapse degeneration. Using a large-scale unbiased genetic modifier screen, we identified genes encoding cytoskeletal and axonal organizing proteins, including Shortstop (Shot), as suppressors of synaptic autophagy. We demonstrate that active Rab39 selectively controls Shot- and Unc104/KIF1A-mediated delivery of autophagy-related Atg9-positive vesicles to synapses. Our findings suggest that Rab39-mediated trafficking in the soma orchestrates a cross-compartmental mechanism that regulates the levels of autophagy at synapses.

Indexed as

AutophagyAutophagy-Related ProteinsDrosophila ProteinsPresynaptic Terminalsrab GTP-Binding ProteinsSynapsesSynaptic VesiclesVesicular Transport ProteinsAnimalsDrosophila melanogasterHumansProtein TransportAutophagy-Related ProteinsDrosophila Proteinsrab GTP-Binding ProteinsVesicular Transport ProteinsDrosophilaGenetic Suppressor ScreenParkinson’s DiseaseRab39Synaptic Autophagy

Identifiers

PMID40841711
PMCPMC12528412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.